These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1109 related articles for article (PubMed ID: 14612849)
1. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms. Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849 [TBL] [Abstract][Full Text] [Related]
2. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148 [TBL] [Abstract][Full Text] [Related]
4. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]
5. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902 [TBL] [Abstract][Full Text] [Related]
6. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. Soini Y; Satta J; Määttä M; Autio-Harmainen H J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152 [TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
8. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance]. Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms. Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173 [TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology. Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871 [TBL] [Abstract][Full Text] [Related]
11. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall. Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734 [TBL] [Abstract][Full Text] [Related]
13. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls. Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785 [TBL] [Abstract][Full Text] [Related]
15. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection. Ishii T; Asuwa N Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655 [TBL] [Abstract][Full Text] [Related]
16. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]. He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658 [TBL] [Abstract][Full Text] [Related]
17. [Effects of doxycycline on the expression of matrix metalloproteinase and tissue inhibitor of MMP in myocardium after acute myocardial infarction: an animal experiment with rats]. Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1288-93. PubMed ID: 15387968 [TBL] [Abstract][Full Text] [Related]
18. Proteolysis of the abdominal aortic aneurysm wall and the association with rupture. Petersen E; Wågberg F; Angquist KA Eur J Vasc Endovasc Surg; 2002 Feb; 23(2):153-7. PubMed ID: 11863333 [TBL] [Abstract][Full Text] [Related]
19. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153 [TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]